The Australia and New Zealand radiology services market size is expected to grow at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2024-2032, driven by the increasing incidence of an aging population and chronic diseases across the region. Australia and New Zealand Radiology Services Market Read more…
The global cardiac biomarker testing market size was valued at USD 4.68 billion in 2023, driven by the increasing prevalence of cardiovascular diseases (CVDs) across the globe. The market size is anticipated to grow at a compound annual growth rate (CAGR) of 8.8% during the forecast period of 2024-2032, achieving Read more…
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer types, making it the most common form of the disease. According to cancer.gov, in 2024, around 234,580 new cases of NSCLC are expected to be diagnosed in the United States alone, with 125,070 deaths predicted. Non-Small Cell Read more…
Gastric Cancer Market Outlook The growing prevalence of gastric cancer is a major driver of advancements in the drug pipeline, with an estimated 27,510 new cases projected in the United States for 2024. Gastric Cancer Drug Pipeline Analysis Report 2024 This includes around 17,070 cases in men and 10,440 in Read more…